ERBB2 and breast carcinoma: To further evaluate the prognostic value of LINC00589 expression, we obtained formalin-fixed and parrffin-embedded (FFPE) samples from an independent cohort of 92 trastuzumab-treated HER2-positive breast cancer patients with available clinical data.